Cardiorespiratory Fitness Reference Standards and Prognostic Stratification in Chinese Patients With Cardiovascular

Haoning Cui1, Xiaojun Wu1, Xiang Xie2

  • 1Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; Department of Cardiac Rehabilitation Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

JACC. Asia
|June 26, 2026
PubMed

Insights

This study establishes cardiorespiratory fitness (CRF) reference standards for Chinese patients with cardiovascular disease (CVD), improving risk stratification for major adverse cardiovascular events (MACE). The new standards show lower CRF in CVD patients compared to healthy adults, aiding personalized care.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Exercise Physiology

Background:

  • Cardiorespiratory fitness (CRF) is crucial for risk stratification in cardiovascular disease (CVD).
  • Current CRF assessment in Chinese CVD patients uses non-specific standards, risking misclassification.
  • Establishing tailored reference standards is vital for accurate risk assessment.

Purpose of the Study:

  • To develop specific CRF reference standards for Chinese patients with CVD.
  • To evaluate the utility of these standards in stratifying major adverse cardiovascular event (MACE) risk.

Main Methods:

  • A multicenter retrospective study of 56,495 Chinese CVD patients (2018-2024).
  • Derived sex- and age-specific CRF percentiles, comparing them to healthy adults.
  • Validated prognostic performance for MACE using Kaplan-Meier and Cox regression in 6,317 patients.

Main Results:

  • Established CRF reference standards showed significant differences across sex, age, and CVD subtype.
  • Chinese CVD patients exhibited lower peak oxygen uptake (73.3%-84.0% of healthy levels).
  • Lower CRF significantly correlated with increased MACE risk (HR 1.46-2.29) and reduced event-free survival.

Conclusions:

  • The study presents the first CRF reference standards for Chinese CVD patients.
  • These standards effectively stratify MACE risk, enhancing prognostic accuracy.
  • Findings support data-driven functional risk assessment and personalized secondary prevention strategies.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History